Antwerp University Hospital (UZA)

Flag of

  +32 3 821 30 00  |     https://www.uza.be/english  |    vragen@uza.be

The Antwerp University Hospital has a Neuromuscular Diseases Centre covering all areas of expertise: Rare muscle diseases ORPHA98472, Rare Peripheral Nerve ORPHA98496
diseases, Neuromuscular Junction ORPHA98491 disorders, Motor Neuron Diseases ORPHA98503, Mitochondrial Diseases ORPHA68380.

It provides ancillary tests for neuromuscular conditions, including Neuromuscular biopsies, Neurophysiology, MRI for NMD, Autonomous nerve system tests and Genetic testing.

The hospital meets the 5th edition of quality standards defined by the Joint Commission International (JCI) and obtained in August 2015 the JCI quality approval.
The labs for pathology, clinical biology and medical genetics have an ISO 15189 accreditation.
The healthcare provider participates in health care quality assessments organized by the regional and federal health authorities.
All research laboratories are under the supervision of the Ethical committee of the hospital.

HCP representation

Prof Jonathan Baets

Substitute representative who will participate as a member of the Board of the Network

Prof Peter de Jonghe

Prof de Jonghe leads the UZA Neuromuscular Centre in Antwerp University Hopsital.

Location

Group membership

Antwerp University Hospital (UZA) participates in the following groups…

Specialised Groups

Muscle diseases
Peripheral Nerve Disease
Motor Neuron Disease
Neuromuscular Junction Defects
Mitochondrial Diseases

Cross Cutting Specialised Groups

Neuromuscular Imaging
Neurophysiology
Neuromuscular Pathology
Genetics

The ERNs are co-funded by the
European Union (Health Programme and CEF)

EU Commission


“EURO-NMD is one of the 24 European Reference Networks (ERNs) approved by the ERN Board of Member States. The ERNs are co-funded by the European Union (Health Programme and CEF).
For more information about the ERNs and the EU health strategy,
please visit ec.europa.eu/health/ern